USE OF AGONISTS OF THE COUPLED RECEIVER TO PROTEIN G, BUT, IN THE TREATMENT OF METABOLIC SYNDROME, ITS COMPONENTS AND THEIR COMPLICATIONS

摘要

g protein coupled receptor agonists, but in the treatment of metabolic syndrome, its components and its complications. The present invention is characterized by the use of g protein-coupled receptor agonists, but as a mechanism of control, prevention and treatment of body levels of triglycerides, cholesterol and glucose, as well as arterial hypertension and possible increase in body weight, characteristic of the metabolic syndrome and its complications. Another feature of the invention is the use of g-protein coupled receptor agonists, but including the angiotensin- (1-7) peptide and its analogs, agonists, peptides or non-peptides as modulators of insulin resistance and intolerance pictures. glucose and the prevention and treatment of related changes. The invention claims the use of g-protein coupled receptor agonists, but formulated with pharmaceutically and pharmacologically acceptable excipients or carriers, and g-protein coupled receptor agonists, but including the angiotensin- (1-7) peptide and analogs thereof , agonists, peptides or non-peptides as modulators of the metabolic syndrome, its diseases and their complications.